SALT LAKE CITY — A Roy man convicted of murder in 2022 will get a new trial after the Utah Court of Appeals reversed his conviction on Thursday. Daniel Lee Johnson's attorney had asked a judge ...

David Edwards has spent over a decade reporting on social justice, human rights and politics for Raw Story. He also writes Crooks and Liars. He has a background in enterprise resource planning and ...

Rep. Chip Roy (R-Texas) confirmed he was not in attendance at the Florida retreat for House Republicans while taking a shot at those who were present. “It is being reported I am not at the so ...

NEW YORK (AP) — A New York judge set a March 2026 trial date on Monday and moved an initial conference from mid-February to next week as the public feud between Blake Lively and her “It Ends ...

It ends in court — next year. Blake Lively and Justin Baldoni are headed to trial on March 9, 2026 to settle their “It Ends With Us” legal dispute. The court date for the case was scheduled ...

The pre-pivotal clinical trial, which included 30 diabetic participants—primarily individuals with Type 1 diabetes—represents a significant milestone in Trinity's mission to deliver affordable ...

Judge Lewis J. Liman scheduled a trial date for Blake Lively and Justin Baldoni's lawsuits Benjamin VanHoose is a Staff Editor on the Movies team at PEOPLE. He has written about entertainment and ...

A Phase III trial demonstrated that adding nivolumab, an immunotherapy drug, to pre-surgery chemotherapy significantly improves cure rates for ER+/HER2− breast cancer, the most common subtype.

Marcus Rashford is set to leave Manchester United this month, with manager Ruben Amorim repeatedly criticising his performances in training and attitude. Most recently, Amorim said he would rather ...

Justin Baldoni and Blake Lively could be headed for a trial on March 9, 2026, a judge said on Monday. The “It Ends With Us” co-stars are suing each other in federal court in New York.

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...